Alkermes (ALKS) EBT (QoQ) (2010 - 2026)
Alkermes (ALKS) EBT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.07 Bn | 7.42 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 96.97% |
| Mar 31, 2026 | -202.57% |
| Dec 31, 2025 | -40.07% |
| Sep 30, 2025 | -3.91% |
| Jun 30, 2025 | 311.31% |
| Mar 31, 2025 | -85.00% |
| Dec 31, 2024 | 54.12% |
| Sep 30, 2024 | -5.56% |
| Jun 30, 2024 | 148.80% |
| Mar 31, 2024 | -19.56% |
| Dec 31, 2023 | -37.10% |
| Sep 30, 2023 | -67.11% |
| Jun 30, 2023 | 2,586.80% |
| Mar 31, 2023 | -109.90% |
| Dec 31, 2022 | 269.94% |
| Sep 30, 2022 | -102.61% |
| Jun 30, 2022 | 26.11% |
| Mar 31, 2022 | -135.36% |
| Dec 31, 2021 | 579.59% |
| Sep 30, 2021 | -569.23% |